Aktis Oncology, Inc. (AKTS) Earnings
NASDAQ·Healthcare·Biotechnology
$20.05
-9.18%
Mkt Cap $1.21B
EPS — Estimate vs Actual
Mkt Cap
$1.21B
P/E
—
Fwd P/E
—
P/S
80.55
Rev TTM
—
EPS TTM
-$0.88
NASDAQ·Healthcare·Biotechnology
$20.05
-9.18%
Mkt Cap $1.21B
Mkt Cap
$1.21B
P/E
—
Fwd P/E
—
P/S
80.55
Rev TTM
—
EPS TTM
-$0.88